UnitedHealth Group (NYSE:UNH) Announces Earnings Results

UnitedHealth Group (NYSE:UNH) released its quarterly earnings data on Thursday. The healthcare conglomerate reported $4.52 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $4.41 by $0.11, RTT News reports. The company had revenue of $72.34 billion for the quarter, compared to analysts’ expectations of $71.24 billion. UnitedHealth Group had a net margin of 5.33% and a return on equity of 22.15%. The business’s revenue was up 11.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.51 EPS. UnitedHealth Group updated its FY 2021 guidance to $18.650-$18.900 EPS and its FY21 guidance to $18.65-18.90 EPS.

UNH opened at $403.55 on Thursday. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.77 and a quick ratio of 0.77. The firm has a fifty day moving average price of $411.69 and a 200 day moving average price of $405.33. UnitedHealth Group has a 1 year low of $299.60 and a 1 year high of $431.36. The stock has a market cap of $380.51 billion, a P/E ratio of 26.65, a P/E/G ratio of 1.62 and a beta of 0.77.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 21st. Shareholders of record on Monday, September 13th were paid a dividend of $1.45 per share. This represents a $5.80 annualized dividend and a yield of 1.44%. The ex-dividend date was Friday, September 10th. UnitedHealth Group’s payout ratio is 34.36%.

In other news, CEO Andrew Witty sold 6,000 shares of the company’s stock in a transaction on Wednesday, July 21st. The shares were sold at an average price of $414.15, for a total transaction of $2,484,900.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO John F. Rex sold 15,438 shares of the company’s stock in a transaction dated Thursday, July 29th. The shares were sold at an average price of $412.04, for a total transaction of $6,361,073.52. The disclosure for this sale can be found here. In the last three months, insiders sold 101,438 shares of company stock valued at $42,396,929. 0.55% of the stock is owned by insiders.

Institutional investors have recently made changes to their positions in the business. Morgan Stanley grew its position in shares of UnitedHealth Group by 9.7% during the second quarter. Morgan Stanley now owns 8,693,237 shares of the healthcare conglomerate’s stock worth $3,481,120,000 after acquiring an additional 768,188 shares during the last quarter. Camden National Bank grew its position in shares of UnitedHealth Group by 5.5% during the fourth quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock worth $667,000 after acquiring an additional 100 shares during the last quarter. Finally, OLD Mission Capital LLC acquired a new stake in shares of UnitedHealth Group during the third quarter worth $439,000. Institutional investors own 86.21% of the company’s stock.

UNH has been the topic of a number of research analyst reports. Barclays increased their price objective on shares of UnitedHealth Group from $435.00 to $465.00 and gave the stock an “overweight” rating in a research report on Friday, July 16th. Citigroup raised their price target on shares of UnitedHealth Group from $450.00 to $480.00 and gave the company a “buy” rating in a research report on Friday, July 16th. Stephens raised their price target on shares of UnitedHealth Group from $440.00 to $460.00 and gave the company an “overweight” rating in a research report on Friday, July 16th. Oppenheimer reaffirmed a “buy” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research report on Thursday, July 15th. Finally, Credit Suisse Group raised their price target on shares of UnitedHealth Group from $430.00 to $462.00 and gave the company an “outperform” rating in a research report on Friday, July 16th. Three equities research analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $447.79.

About UnitedHealth Group

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Story: History of the Euro STOXX 50 Index

Earnings History for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.